Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06024837

Performance of Spectral CT-scan in Patients With Metastatic Colorectal Cancer: a Prospective Multicentre Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Spectral CT is a rapidly expanding imaging modality that allows a reduction in iodine dose and irradiation compared to conventional scanning. It uses the difference in attenuation of the material according to the two different energy levels of the incident x-ray beams. The dual-energy scanner has a wide range of clinical applications, particularly in abdominal imaging.

Detailed description

First of all, the virtual creation of mono-energy images between 40 and 140 keV has shown subjective and objective improvement of tumor detection of hypovascular lesions using low energies (40keV). It has been shown to be of interest in vascular and cardiac imaging, and to reduce artefacts in bone imaging. However, its performance in oncology analysis has been little studied. The selection of patients for peritoneal and hepatic carcinosis surgery is fundamental, as surgery allows a prolongation of survival, but are associated with a non-negligible morbi-mortality rate. Spectral CT provides improved detection of peritoneal carcinosis and liver metastases of colorectal cancer compared to conventional CT acquisition.

Conditions

Interventions

TypeNameDescription
OTHERCT ImagesAnalysis of CT images of peritoneal and/or liver metastases from colorectal cancer

Timeline

Start date
2023-06-07
Primary completion
2025-01-01
Completion
2025-06-01
First posted
2023-09-06
Last updated
2024-09-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06024837. Inclusion in this directory is not an endorsement.